ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
35
views
0
references
Top references
cited by
392
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,429
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Trial of Psilocybin versus Escitalopram for Depression
Author(s):
Robin Carhart-Harris
1
,
Bruna Giribaldi
1
,
Rosalind Watts
1
,
Michelle Baker-Jones
1
,
Ashleigh Murphy-Beiner
1
,
Roberta Murphy
1
,
Jonny Martell
1
,
Allan Blemings
1
,
David Erritzoe
1
,
David J. Nutt
1
Publication date
Created:
April 15 2021
Publication date
(Print):
April 15 2021
Journal:
New England Journal of Medicine
Publisher:
Massachusetts Medical Society
Read this article at
ScienceOpen
Publisher
PubMed
Further versions
open (via free article)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Measurement of Glucocorticoid Receptor Signaling in Major Depression
Author and article information
Journal
Title:
New England Journal of Medicine
Abbreviated Title:
N Engl J Med
Publisher:
Massachusetts Medical Society
ISSN (Print):
0028-4793
ISSN (Electronic):
1533-4406
Publication date Created:
April 15 2021
Publication date (Print):
April 15 2021
Volume
: 384
Issue
: 15
Pages
: 1402-1411
Affiliations
[
1
]
From the Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London.
Article
DOI:
10.1056/NEJMoa2032994
PubMed ID:
33852780
SO-VID:
e3f5875c-c98b-44ae-9427-22d9bcf5846b
Copyright ©
© 2021
License:
http://www.nejmgroup.org/legal/terms-of-use.htm
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
3,429
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression
Authors:
Dan Yaniv
,
Lois Michelle Ramondetta
,
Lorenzo Cohen
…
Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge
Authors:
Marcha Verheijen
Comparison of Bioavailability and Bioequivalence of Generic and Brand Name Formulations of Escitalopram Oxalate Tablets in Healthy Chinese Population Under Fasting and Fed Conditions
Authors:
Qiuying Li
,
Hua Huo
,
Wenli Hu
…
See all similar
Cited by
388
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
Authors:
Guy M. Goodwin
,
Scott Aaronson
,
Oscar Álvarez
…
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder : A Randomized Clinical Trial
Authors:
Michael P Bogenschutz
,
Stephen Ross
,
Snehal R. Bhatt
…
Increased global integration in the brain after psilocybin therapy for depression
Authors:
Richard E. Daws
,
Christopher Timmermann
,
Bruna Giribaldi
…
See all cited by